| Walgreen #16396 | |
| 805 Pamplico Hwy, Suite B-130, Florence, South Carolina 29505 | |
| (843) 799-6270 |
| Name | Walgreen #16396 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 805 Pamplico Hwy, Suite B-130, Florence, South Carolina 29505 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (843) 799-6270 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Parent education programs delivered through pediatric primary care offices appeared to increase parent-child interactions during infancy in at-risk families, according to a report in the January issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
The Annual ACA Convention attendees will be the first to see 2 new products from Prime Coat Coating Systems. Path-O-Cide and Fiber Coat with Kevlar will revolutionize the way that correctional facilities are constructed and refurbished for the near future.
Labopharm Inc. today announced the U.S. Food and Drug Administration (FDA) has approved OLEPTRO(TM) (trazodone hydrochloride) Extended Release Tablets, a novel once-daily formulation of the antidepressant trazodone, for the treatment of major depressive disorder (MDD) in adults. OLEPTRO(TM) utilizes CONTRAMID(R), Labopharm's clinically validated technology that controls the release of active substances within oral medications.
Researchers from CNRS, INSERM and Toulouse University Hospital have demonstrated how the parasite Plasmodium falciparum, which causes severe forms of malaria, is able to circumvent the action of artemisinin and its derivatives, which are today the first-line drugs used to treat this disease. This study supplies some important findings that will enable a clearer understanding of the mechanisms of resistance to antimalarial drugs and the testing of novel therapeutic strategies in a context where the drug resistance of parasites is of increasing concern.
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
› Verified 9 days ago
| NPI Number | 1336504695 |
| Organization Name | WALGREEN CO . |
| Doing Business As | WALGREENS #16396 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 805 Pamplico Hwy Ste B130, Florence, SC 29505 |
| Phone Number | 843-799-6270 |
News Archive
Parent education programs delivered through pediatric primary care offices appeared to increase parent-child interactions during infancy in at-risk families, according to a report in the January issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
The Annual ACA Convention attendees will be the first to see 2 new products from Prime Coat Coating Systems. Path-O-Cide and Fiber Coat with Kevlar will revolutionize the way that correctional facilities are constructed and refurbished for the near future.
Labopharm Inc. today announced the U.S. Food and Drug Administration (FDA) has approved OLEPTRO(TM) (trazodone hydrochloride) Extended Release Tablets, a novel once-daily formulation of the antidepressant trazodone, for the treatment of major depressive disorder (MDD) in adults. OLEPTRO(TM) utilizes CONTRAMID(R), Labopharm's clinically validated technology that controls the release of active substances within oral medications.
Researchers from CNRS, INSERM and Toulouse University Hospital have demonstrated how the parasite Plasmodium falciparum, which causes severe forms of malaria, is able to circumvent the action of artemisinin and its derivatives, which are today the first-line drugs used to treat this disease. This study supplies some important findings that will enable a clearer understanding of the mechanisms of resistance to antimalarial drugs and the testing of novel therapeutic strategies in a context where the drug resistance of parasites is of increasing concern.
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
› Verified 9 days ago
News Archive
Parent education programs delivered through pediatric primary care offices appeared to increase parent-child interactions during infancy in at-risk families, according to a report in the January issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
The Annual ACA Convention attendees will be the first to see 2 new products from Prime Coat Coating Systems. Path-O-Cide and Fiber Coat with Kevlar will revolutionize the way that correctional facilities are constructed and refurbished for the near future.
Labopharm Inc. today announced the U.S. Food and Drug Administration (FDA) has approved OLEPTRO(TM) (trazodone hydrochloride) Extended Release Tablets, a novel once-daily formulation of the antidepressant trazodone, for the treatment of major depressive disorder (MDD) in adults. OLEPTRO(TM) utilizes CONTRAMID(R), Labopharm's clinically validated technology that controls the release of active substances within oral medications.
Researchers from CNRS, INSERM and Toulouse University Hospital have demonstrated how the parasite Plasmodium falciparum, which causes severe forms of malaria, is able to circumvent the action of artemisinin and its derivatives, which are today the first-line drugs used to treat this disease. This study supplies some important findings that will enable a clearer understanding of the mechanisms of resistance to antimalarial drugs and the testing of novel therapeutic strategies in a context where the drug resistance of parasites is of increasing concern.
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
› Verified 9 days ago
A-1 Medical Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1407 S Church St, Florence, South Carolina 29505 Phone: (846) 661-2166 | |
Apria Healthcare Llc Type: Medicare Supplier Location: 799n Cashua Dr, Florence, South Carolina 29501 Phone: (843) 665-6294 | |
Florence Brace & Limb Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2293 S Irby St, Florence, South Carolina 29505 Phone: (843) 665-1102 | |
Hanger Prosthetics & Orthotics Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 326 S Dargan St, Florence, South Carolina 29506 Phone: (843) 669-8509 | |
Lincare Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2325 Prosperity Way, Florence, South Carolina 29501 Phone: (843) 669-7900 |